Stock bottomed out, prices rose again, drug companies set up production bases

Experts predict that this year's total output will reach more than 8,500 tons, but now there are three months away from the production of new, saying that prices are sharply cut is still too early since June, Panasonic prices "high temperature" is not refundable, listed companies involved The share prices of Tasly, Yunnan Baiyao and Kangmei Pharmaceutical also rose. According to the latest data from the Chinese herbal medicine company, Tiandi.com, the price of 120 first three-seven production areas is about 680-700 yuan/kg; the price of 40 first 37 yuan is 770-800 yuan/kg; the price of 20 first three-seventh is 880-900 yuan/ kg. It is understood that the current retail price of 20 of 37 on the Yiwu market in Zhejiang has reached 1,200 yuan/kg. In March of this year, the price of the origin of 20 three-seventy-seven was only 600 yuan/kg. In just three months, the price of March rose again.

The year-on-year increase in production in 2012 According to Cui Xiuming, director of the Sanqi Research Institute of Wenshan Prefecture in Yunnan Province, in 2012, the planting area of ​​Yunnan Sanqi producing area was about 160,000 mu, and the harvested area was about 50,000 mu; the planting area in 2013 will reach More than 240,000 mu, more than doubled in 2007, of which more than 60,000 acres of harvested area, the output may exceed 10 million kilograms, oversupply situation will emerge. Some industry insiders predict that the downward trend of prices in March and July will not be avoided.

According to an interview with the “Securities Daily” reporter, Jiang Erguo, director of the Information Center of the Chinese Herbal Medicine Network Information Center and deputy director of the Information Center of the Chinese Medicines Association, said that according to the 2012 507 mu harvest area of ​​50,000 mu, normal production of 170-200 kg/mu, this year The total output of March 7 will reach more than 8,500 tons. However, Jiang Erguo believes that it is too early to say that Panzhihua will significantly lower prices, because there are still three months before the new product is produced. “We will not be able to forecast prices until September production is basically established.”

Regarding the reasons for the high prices and high prices in the first half of this year, Cui Xiu-ming believes that it is the contradiction between supply and demand. According to calculations, the current annual demand for Sanqi is about 7,000 tons. In the past three years, the output of Panax rose slightly, but it has not been more than 5,000 tons, and the average annual gap is 2,000 tons. Although there are offsets for inventory from 2006 to 2008, by the beginning of 2012, the excess inventory has been basically consumed.

According to Jiang Erguo's analysis, the output of Panax notoginseng was very good in 2006-2008, resulting in oversupply and a certain amount of inventory. In 2009-2011, due to weather drought and other factors that affected production, they had to use the first three years of inventory, and these stocks could not Completely making up for the shortfall in demand, stocks basically run out in the first half of this year, causing a rise in the price of Panax rose again.

The current market hopes to increase production this year, so that from March to March, supply will exceed demand and supply prices will recover. From the demand side, "the current annual demand is between 6,000 and 7,000 tons, because of the price effect, there may be fluctuations." Jiang Erguo said that from the supply side, it is not easy to say whether the harvest data of 50,000 mu are accurate because This year, the planting area is expanding and there are certain difficulties in complete statistics."

According to industry estimates, the planting area of ​​Sanqi in Yunnan will reach more than 240,000 mu in 2013, which is more than doubled from 2007. The harvested area has more than 60,000 mu and the output may exceed the 10,000-ton mark, which will greatly ease Contradiction between supply and demand, the price of "seven rockets" may not be repeated.

High price stimulation of drug companies to build production bases The price rise of March 7 has caused the market to face a mixed bag of diseases. According to the information provided by the Chinese herbal medicine network, the recent arrivals of new goods on the market are mostly due to the fact that the seven rural arable lands in the producing areas have been excavated. This has led to a reversal of the rising market. The downstream companies are also facing huge cost pressures. The powerful pharmaceutical companies invariably set up their own production bases in Wenshan, Yunnan, the main producing area of ​​the 37th.

According to public information, Tasly was the first domestic pharmaceutical company to invest in Sanqi planting industry in Wenshan City. Since 2010, Tianjin Tasly Group has invested RMB136 million through its wholly-owned subsidiary, Yunnan Tianshili Sanqi Planting Co., Ltd., and plans to use a seven-year period (2010 to 2016) to build the Sanqi Seven-Family Breeding Base, with a total area of ​​1080 acres and Sanqi Production. The base is 5,400 mu. After the project construction reaches the design target, it will annually produce 470 tons of high-quality products and 100 tons of medicinal materials.

In March 2010, the Baiyun Mountain and Huang Medicines initialed a framework agreement with the People's Government of Dangshan County of Wenshan Prefecture of Yunnan Province. Both parties jointly carried out a demonstration base of 3,000 mu of industrialization in the Wenshan Prefecture of Yunnan Province. Wenshan Baiyun Mountain and Huangqi Sanqi GAP Industry Base construction.

Medical Mask

Medical masks are mostly made of one or more layers of nonwoven fabrics. The main production processes include meltblown, spunbond, hot air or needle punching. They are equivalent to resisting liquids, filtering particles and bacteria, and are a kind of medical protection. textile.
The medical mask is composed of a mask face and a tightening belt. The mask face is divided into inner, middle and outer layers. The inner layer is skin-friendly (general hygienic gauze or non-woven fabric), and the middle layer is an isolation filter layer (ultra-fine polypropylene Fiber melt-blown material layer), the outer layer is a special material antibacterial layer (non-woven fabric or ultra-thin polypropylene melt-blown material layer).
According to performance characteristics and scope of application, medical masks can be divided into: medical protective masks, medical surgical masks, ordinary medical masks.
1. Medical Protective Mask
Medical protective masks are suitable for the protection of airborne respiratory tract infectious diseases by medical staff and related staff. It is a close-fitting self-priming filter medical protection article with a high protection level, especially suitable for contact with airborne transmission during diagnostic activities Or worn by patients with respiratory infections transmitted by droplets at close range. It can filter the particles in the air, block droplets, blood, body fluids, secretion droplets, etc. It is a disposable product. Medical protective masks can prevent most pathogens such as bacteria and viruses. WHO recommends medical personnel to use protective masks against particles to prevent viral infections in hospital air. .
Medical protective masks comply with GB19083-2003 "Technical Requirements for Medical Protective Masks". Important technical indicators include non-oily particle filtration efficiency and airflow resistance. The specific indicators are as follows: [3]
1) Filtration efficiency: Under the condition of air flow (85 ± 2) L / min, the filtration efficiency of aerodynamic median diameter (0.24 ± 0.06) μm sodium chloride aerosol is not less than 95%, which is in accordance with N95 ( Or FFP2) and above. It can block infectious agents with a diameter of less than 5 μm transmitted by air or close contact with infectious agents transmitted by droplets.
2) Inhalation resistance: under the above flow conditions, the inhalation resistance does not exceed 343.2Pa (35mmH2O).
3) For the samples sprayed on the mask under the pressure of 10.9Kpa (80mmHg), no technical indicators such as penetration should appear on the inside of the mask.
4) The nose mask must be equipped with a nose clip, which is made of bendable plastic material and has a length> 8.5cm.
5) Synthetic blood is sprayed towards the mask sample at a pressure of 10.7kPa (80mmHg), there should be no penetration inside the mask.
2. Medical Surgical Mask
Medical surgical masks are suitable for the basic protection of medical staff or related personnel, as well as the protection against the spread of blood, body fluids and splashes during the invasive operation. The protection level is medium and has certain respiratory protection performance. It is mainly used in clean environments with a cleanliness level of less than 100,000, operating in the operating room, nursing patients with low immune function and performing body cavity puncture and other operations. Medical surgical masks can block most bacteria and some viruses, can prevent medical staff from being infected, and can also prevent the microorganisms carried by medical staff's breath from being directly discharged, posing a threat to patients undergoing surgery. Medical surgical masks require the filtration efficiency of bacteria to be above 95%. Disposable medical surgical masks should also be issued to suspicious respiratory patients to prevent the threat of infection to other hospital personnel and reduce the risk of cross-infection, but to avoid infections that are less effective than medical protective masks. .
It complies with YY0469-2004 "Technical Requirements for Medical Surgical Masks", and important technical indicators include filtration efficiency, bacterial filtration efficiency and respiratory resistance. The specific indicators are as follows:
1) Filtration efficiency: Under the condition of air flow (30 ± 2) L / min, the filtration efficiency of aerodynamic median diameter (0.24 ± 0.06) μm sodium chloride aerosol is not less than 30%.
2) Bacterial filtration efficiency: under specified conditions, the filtration efficiency of Staphylococcus aureus aerosol with an average particle diameter of (3 ± 0.3) μm is not less than 95%; the bacterial filtration rate should be ≥95%; the The filtration rate should be ≥30%.
3) Breathing resistance: Under the condition of filtration efficiency flow, the inhalation resistance does not exceed 49Pa, and the exhalation resistance does not exceed 29.4Pa. When the pressure difference △ P of gas exchange on both sides of the mask is 49Pa / cm, the gas flow rate should be ≥ 264mm / s.
4) Nose clips and mask straps: Nose clips should be provided on the mask. The nose clips are made of plastic materials and the length of the nose clip should be greater than 8.0cm. The mask band should be easy to wear and take, and the breaking strength at the connection point between each mask band and the mask body should be greater than 10N.
5) Synthetic blood penetration: After 2ml of synthetic blood is sprayed at the pressure of 16.0kPa (120mmHg) towards the outer side of the mask, no penetration should occur on the inner side of the mask.
6) Flame retardant performance: The mask material should be made of non-flammable materials, and the mask burns less than 5s after leaving the flame.
7) Residual amount of ethylene oxide: For masks sterilized by ethylene oxide, the residual amount of ethylene oxide should be less than 10μg / g.
8) Skin irritation: The primary irritation index of the mask material should be ≤0.4, and there should be no sensitization reaction.
9) Microbial indicators: total bacterial colonies ≤20CFU / g, and no coliform bacteria, Pseudomonas aeruginosa, Staphylococcus aureus, hemolytic streptococci and fungi shall be detected.
3. Ordinary medical mask
Ordinary medical masks are used to block spouts exhaled from the oral cavity and nasal cavity, and can be used for one-time hygiene care in ordinary medical environments with the lowest protection level. It is suitable for general hygiene care activities, such as sanitary cleaning, liquid distribution, cleaning bed units, etc., or the blocking or protection of particles other than pathogenic microorganisms such as pollen.
Conforms to the relevant registered product standard (YZB), generally lacks the filtration efficiency requirements for particles and bacteria, or the filtration efficiency requirements for particles and bacteria are lower than medical surgical masks and medical protective masks, only reaching 20.0% for 0.3μm diameter aerosol -25.0% protection effect, can not reach the filtration efficiency of particles and bacteria, can not effectively prevent pathogens from invading through the respiratory tract, can not be used for clinical invasive operations, nor can it protect particles and bacteria and viruses, only limited to dust particles Or aerosol plays a certain mechanical barrier.
Instructions:
1. Carefully cover the mouth and nose with a mask and fasten it to minimize the gap between the face and the mask;
2. Avoid touching the mask when using it-after touching the used mask, for example to remove or clean the mask, wash your hands with soap and water or use alcohol hand sanitizer;
3. After the mask is wet or contaminated with moisture, replace with a new clean and dry mask;
4. Do not reuse disposable masks. Disposable masks should be discarded after each use.

Medical Mask,Medical Surgical Mask,Disposable Medical Face Mask,Disposable Non Woven Mask

Guangzhou Aikangli Medical Technology Co., Ltd. , https://www.aikanli.com